2nd Annual World Congress: Lessons Learned from Rare Disease and Personalised Medicine Approaches
Date: 17 September 2018 - 18 September 2018
Royal Sonesta Boston
40 Edwin H Land Boulevard
Email: [email protected]
Charles River’s 2nd Annual World Congress brings together industry leaders for a two-day conference that includes a mix of presentations, panel discussions and short technology talks covering a wide range of strategies for successful drug discovery. While the focus of the conference is rare diseases and personalised medicine across various therapeutic areas, there will be a broader discussion around drug discovery approaches and innovative therapeutic modalities that are being employed in the rare disease space.
Here are a few reasons why you should register:
- The speakers: Learn from and network with the 18 scientists and patient advocates from academia, industry, and foundations including keynote lectures from speakers with the Cystic Fibrosis Foundation and AFM-Telethon.
- Charles River Annual Research Award: We are proud to honor a young patient-entrepreneur, David Hysong, founder of Shepherd Therapeutics, whose mission is to develop new therapies for rare cancers.
- Networking: Meet and discuss cutting-edge science and technology platforms with top scientists and entrepreneurs from the Greater Boston area.
- Patient advocacy: Meet Mike Porath, a journalist who founded theMighty.com, and Mark Dant – whose story was featured on 60 Minutes, CBS News and other media outlets.
This conference is truly groundbreaking in the depth and breadth of cutting-edge science, combined with inspirational stories of patients and their caregivers.
You have two options for attending the conference:
Option 1: Virtual attendance
Option 2: In person